Epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor (TKI) has been widely used in non-small cell lung cancer (NSCLC), and the incidence of EGF
Purpose: Concurrent chemoradiotherapy with 5-fluorouracil and cisplatin are often associated with significant incidence of toxic effects in elderly patients wit